Companies: 10,795·Total market cap: $144.5T
Caribou Biosciences, Inc.

Caribou Biosciences, Inc.

CRBUNASDAQHealthcare● Active
$1.67
+$0.08(+4.70%)
Market Cap$165631560
P/E Ratio—
52W High$3.535
52W Low$1.04
Cash on HandFinancialsRevenue

Caribou Biosciences, Inc. (CRBU) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CRBU · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$139.3M▼ -33.5% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$12.4M
cashAndCashEquivalents
Short-Term Investments
$127.0M
shortTermInvestments
YoY Change vs Prior Year
-33.5%
vs prior fiscal year
Latest Quarter
$117.6M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$139.3MCash on Hand
Total Debt$27.2MTotal Debt
Net Cash / Net Debt+$112.1MNet Cash Position
Cash vs Debt Ratio
Cash 84%Debt 16%

Caribou Biosciences, Inc. has a net cash position of $112.1M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$139.3M − $27.2M = +$112.1M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CRBU annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$139.3M-33.5%
Dec 31, 2024$209.5M-36.3%
Dec 31, 2023$328.8M+32.8%
Dec 31, 2022$247.7M-34.1%
Dec 31, 2021$375.8M+2255.9%
CRBU cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Caribou Biosciences, Inc.
Caribou Biosciences, Inc.YOU
CRBU
$139.3M83.9%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Caribou Biosciences, Inc. (CRBU) cash on hand as of December 31, 2025 is $139.3M, comprising $12.4M in cash and cash equivalents (CCE) plus $127.0M in short-term investments — reported as Caribou Biosciences, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Caribou Biosciences, Inc. cash reserves or cash position.

Caribou Biosciences, Inc. annual cash on hand history shows decreased -33.5% in 2025: decreased -33.5% in 2025. Caribou Biosciences, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Caribou Biosciences, Inc. carries total debt of $27.2M against cash of $139.3M, resulting in a net cash position of +$112.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

CRBU cash on hand · 5 questions

As of December 31, 2025, Caribou Biosciences, Inc. (CRBU) has $139,340,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $12,360,000 in cash and cash equivalents (CCE) plus $126,980,000 in short-term investments. Latest quarter (March 31, 2026): $117,626,000. Data sourced from the annual 10-K filing via FMP.

CRBU cash on handCRBU cash reservesCRBU cash 2025how much cash does CRBU have

▸ Source: FMP /balance-sheet-statement · US GAAP · Caribou Biosciences, Inc. · Caribou Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025